logo
Mainstreet Equity Corp. Announces Normal Course Issuer Bid

Mainstreet Equity Corp. Announces Normal Course Issuer Bid

Business Wire30-05-2025
CALGARY, Alberta--(BUSINESS WIRE)--Mainstreet Equity Corp. ('Mainstreet' or the 'Corporation') (TSX:MEQ) today announced that the Toronto Stock Exchange ('TSX') has accepted its notice of intention to make a normal course issuer bid to purchase outstanding common shares of the Corporation ('Shares') on the open market in accordance with the rules of the TSX.
The Corporation is authorized to purchase up to 475,359 Shares under the normal course issuer bid, representing approximately 10% of its public float of issued and outstanding Shares, as of May 30, 2025. As of that date, there were 9,318,818 Shares issued and outstanding. The average daily trading volume of the Shares for the past six months ended April 30, 2025, calculated in accordance with the rules of the TSX, was 4,082 and Mainstreet is subject to a daily repurchase limit of 1,020 Shares. Mainstreet intends to commence the normal course issuer bid on June 3, 2025 and terminate the bid on June 2, 2026 or such earlier time as the bid is completed or terminated at the option of Mainstreet.
All shares purchased under this bid will be purchased in the open market through the facilities of the TSX and/or alternative Canadian trading systems at the prevailing market price at the time of such transaction. Shares acquired under the bid will be cancelled.
Mainstreet intends to acquire Common Shares from time to time in amounts and prices which its management believes are favourable and consistent with prudent economic and financial considerations. During the period between June 3, 2024 and the date hereof, Mainstreet repurchased Nil Shares under its previous normal course issuer bid. Mainstreet had approval from the TSX to acquire up to 475,229 Shares under such previous normal course issuer bid.
Mainstreet's Board of Directors believes that, from time to time, the market price of its Shares may not reflect their underlying value. At such times, the Board of Directors believe that the purchase of Shares for cancellation pursuant to the normal course issuer bid is in the best interests of Mainstreet and its shareholders, as the cancellation of the Shares will increase the value of the remaining Shares.
Forward-Looking Information
Certain statements contained herein constitute "forward-looking statements" as such term is used in applicable Canadian securities laws. These statements relate to, among other things, Mainstreet's intentions to acquire Shares pursuant to the normal course issuer bid, the timing of such bid and that the repurchase and cancellation of the Shares pursuant to the bid is in the best interests of the shareholders and that it will increase the value of the remaining Shares. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions of future events or performance (often, but not always, using such words or phrases as "expects" or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "estimates" or "intends", or stating that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved) are not statements of historical fact and should be viewed as forward-looking statements.
Such forward-looking statements are not guarantees of future events or performance and by their nature involve known and unknown risks, uncertainties and other factors, including those risks described in the Corporation's Annual Information Form under the heading "Risk Factors" and the failure to realize anticipated benefits of the normal course issuer bid, that may cause the actual results, performance or achievements of the Corporation to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Although the Corporation has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, other factors may cause actions, events or results to be different than anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate as actual results and future events could vary or differ materially from those anticipated in such forward-looking statements. Accordingly, readers should not place undue reliance on forward-looking statements contained herein.
Forward-looking statements are based on management's beliefs, estimates and opinions on the date the statements are made, and the Corporation undertakes no obligation to update forward-looking statements if these beliefs, estimates or opinions should change, except as required by applicable securities laws or as otherwise described therein.
Certain information set out herein may be considered as "financial outlook" within the meaning of applicable securities laws. The purpose of this financial outlook is to provide readers with disclosure regarding the Corporation's reasonable expectations as to the anticipated results of its proposed business activities for the periods indicated. Readers are cautioned that the financial outlook may not be appropriate for other purposes.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

AI Analyst Predicts 50% Upside for HIMS Stock While Wall Street Stays Cautious
AI Analyst Predicts 50% Upside for HIMS Stock While Wall Street Stays Cautious

Business Insider

timean hour ago

  • Business Insider

AI Analyst Predicts 50% Upside for HIMS Stock While Wall Street Stays Cautious

While Wall Street analysts remain cautious on Hims & Hers Health (HIMS), TipRanks' A.I. Stock Analysis tool shows strong confidence in the telehealth company's growth. Notably, TipRanks' AI sets a price target of $72 for HIMS stock, implying a 50% upside from current levels, compared with the Wall Street average of $49.11, which indicates only about 2.4% potential growth. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. For context, TipRanks' A.I. Stock Analysis delivers automated, data-driven evaluations of stocks based on key performance metrics, giving investors a clear and concise snapshot of a stock's potential. Notably, HIMS earns a strong score of 74 out of 100 on the tool. AI Analyst Highlights Earnings and Positive Outlook Hims & Hers Health's A.I. score highlights recent Q2 financials and an overall positive outlook. The earnings call showcased solid revenue and subscriber growth, along with expansion into new markets and healthcare services. Notably, Hims & Hers Health saw its subscriber count rise 31% to 2.4 million in Q2. Meanwhile, adjusted EBITDA more than doubled, reaching $82.2 million. On the downside, the company faced challenges, including a drop in GLP‑1 revenue, negative free cash flow, and rising G&A and technology expenses. Specifically, the company's free cash flow took a significant hit, dropping to a negative $69.4 million as of June 30, 2025, compared with a positive $47.6 million a year earlier. The A.I. tool also provides a summary of the company's recent earnings, highlighting both positive and negative updates. A screenshot is shown below for reference. Overall, the A.I. tool sees past the recent short-term volatility. With a growing customer base, new offerings, and market expansion, the current dip could be a buying opportunity for investors focused on the bigger picture. Wall Street Remains Cautious on HIMS Stock After the earnings release, Wall Street remains cautious on HIMS stock. Needham's four-star-rated analyst Ryan MacDonald maintained his Hold rating. He noted that the company's upcoming hormonal health launch and Canadian expansion in 2026 offer growth potential. However, he is concerned that the near-term performance is still heavily tied to weight-loss products, which face regulatory uncertainty. Meanwhile, BofA's top-rated analyst Allen Lutz maintained his Sell rating on HIMS at a price target of $28, predicting a downside of over 40%. Lutz stated that the company is dealing with several short-term challenges, including slow growth in its core business, which could put additional pressure on the GLP-1 segment. He believes that the second half of the year may be even tougher, and near-term cash flow is expected to remain limited as investments continue. Is HIMS Stock a Good Buy? Overall, Wall Street analysts have a Hold consensus rating on HIMS stock based on two Buys, seven Holds, and two Sells assigned in the last three months. The average HIMS stock price target of $49.11 implies an upside of 2.4% from the current trading level.

Hydro One Q2 Profit Rises on Higher Rates, Energy Demand
Hydro One Q2 Profit Rises on Higher Rates, Energy Demand

Yahoo

timean hour ago

  • Yahoo

Hydro One Q2 Profit Rises on Higher Rates, Energy Demand

Hydro One Ltd. (TSX:H) posted a 12% year-over-year earnings gain in Q2 2025, driven by Ontario Energy Board-approved rate hikes and stronger electricity consumption, as the utility continues large-scale grid investments to meet the province's surging power demand. For the quarter ended June 30, Hydro One reported net income of C$327 million, or C$0.54 per share, up from C$292 million (C$0.49) in Q2 2024. Revenue rose to C$2.07 billion from C$2.03 billion, with revenues net of purchased power up 7% to C$1.17 billion. The gains were fueled by 2025 transmission and distribution rate increases and higher consumption, partially offset by elevated depreciation, asset removal, and financing costs. Context The results come as Ontario released its first Integrated Energy Plan in June, projecting robust electricity demand growth through 2050 and outlining new transmission projects. Hydro One—Ontario's largest electricity transmission and distribution utility—has stepped up capital spending, investing C$913 million in Q2 and bringing C$591 million of assets into service. These upgrades target aging infrastructure, storm restoration, and connecting new generation and load customers. The quarter also saw the ratification of a new labor agreement with the Power Workers' Union covering front-line and customer service roles, as well as the launch of the Ice Storm 2025: Recovery Grant, providing up to C$10,000 to 50 municipalities and First Nations impacted by the spring storm. Sustainability & Recognition Hydro One released its 2024 sustainability report, marking a decade of ESG disclosures, and earned multiple accolades, including its 10th straight year on Corporate Knights' 'Best 50 Corporate Citizens in Canada' list and spots on Forbes' 'Canada's Best Employers for Company Culture' and TIME's 'Canada's Best Companies 2025.' Dividend & Outlook The company declared a quarterly dividend of C$0.3331 per share, payable September 29. With a regulated rate base expected to reach C$28.5 billion in 2025, Hydro One is positioned to benefit from Ontario's grid expansion and electrification efforts. However, higher financing charges and storm-related asset costs underscore the pressures of maintaining and upgrading one of North America's largest provincial power networks. Hydro One shares closed Q2 with a market capitalization of C$29.4 billion, and the utility remains a central player in meeting Ontario's energy reliability and growth goals amid a rapidly shifting demand landscape. Read this article on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Canadian approval of Washington crashes under Trump
Canadian approval of Washington crashes under Trump

Politico

timean hour ago

  • Politico

Canadian approval of Washington crashes under Trump

The drop in support for the U.S. government comes as Trump has engaged in a protracted battle with America's northern neighbor, hitting Canada with steep import tariffs and floating the idea of annexing the country, a proposal that sparked fierce backlash among Canadian citizens and leadership. Less than half of Canadians have generally approved of U.S. leadership since 2017. But Canadians warmed to Washington under the Biden administration, with U.S. leadership briefly receiving a net-positive approval rating in 2021. At the same time, Canadians' approval of their own leadership rose nearly 20 percentage points from last year, with nearly 60 percent of Canadians approving of the country's leaders following Prime Minister Mark Carney's April election win. Carney has taken a more conciliatory approach to the Trump administration, privately courting Trump in his attempts to secure a trade truce even as he has publicly pushed back on the White House's aggressive stance toward Canada. The poll was conducted by telephone from May 20-June 30, 2025 with a random sample of approximately 1,014 Canadian adults. The margin of sampling error is plus or minus 3.6 percentage points.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store